Contrast Media Market Size, Share, Growth Analysis, By Type(Iodinated Contrast Media, Gadolinium-based Contrast Media, Microbubble Contrast Media, Barium-based Contrast Media), By Form(Liquid Contrast Media, Powder Contrast Media, Other Forms), By Modality(X-RAY, CT, MRI, Ultrasound), By Route of Administration(Intravascular Route [Intravenous (IV) route, Intra-arterial (IA) route], Oral Route, Rectal Route), By Indication(Cardiovascular Disease, Cancer, Gastrointestinal Disorders, Musculoskeletal Disorders), By Application(Radiology, Interventional Radiology, Interventional Cardiology), By End User(Hospitals, Clinics, And Ambulatory Surgery Centers, Diagnostic Imaging Centers), By Region - Industry Forecast 2024-2031


Report ID: SQMIG35B2070 | Region: Global | Published Date: September, 2024
Pages: 260 |Tables: 91 |Figures: 75

Contrast Media Market Insights

Global Contrast Media Market size was valued at USD 6.10 billion in 2022 and is poised to grow from USD 6.55 billion in 2023 to USD 11.60 billion by 2031, growing at a CAGR of 7.4% during the forecast period (2024-2031).

Diagnostic imaging procedures, such as ultrasound, X-rays, and cutting-edge imaging equipment like MRI & CT scans, are becoming more common due to the rising frequency of complicated comorbidities and chronic illnesses. For instance, GE Healthcare's Clariscan, a contrast agent used for macrocyclic MRI, was approved by the U.S. FDA in November 2019. These goods aid in determining the necessity of perioperative scans before operations and therapy in interventional procedures, which is projected to promote market expansion. According to the National Health Council, 81 million Americans had several chronic ailments in 2019, which indicates a high frequency of chronic conditions. Nearly 157 million Americans were expected to be impacted by chronic diseases in the U.S.

Older persons are more likely to have chronic diseases with many comorbidities. According to the National Council on Aging, about 80% of adults 65 and older have at least one chronic illness, and nearly 70% of Medicare recipients have more than two. By 2034, it is predicted that approximately 77.0 million Americans will be 65 and older.

Furthermore, heart failure is one of the major causes of mortality in the United States and is becoming increasingly common there, according to a report from the American Heart Association. About 659,000 Americans will pass away in 2019 as a result of cardiovascular disorders. According to estimates, 46% more people will have heart disease by 2031. These factors will drive the demand for contrast media in the global market during the forecast period.

US Contrast Media Market is poised to grow at a sustainable CAGR for the next forecast year.

Market snapshot - 2024-2031

Global Market Size

USD 2.98 billion

Largest Segment

X-ray/CT

Fastest Growth

ultrasound

Growth Rate

4.01% CAGR

Global Contrast Media Market 2021-2028 ($ Bn)
Country Share for North America Region- 2021 (%)

To get more reports on the above market click here to Buy The Report

Contrast Media Market Segmental Analysis

Global Contrast Media Market is segmented by Type, Form, Modality, Route of Administration, Indication, Application, End User, and region. Based on Type, the market is segmented into Iodinated Contrast Media, Gadolinium-based Contrast Media, Microbubble Contrast Media, and Barium-based Contrast Media. Based on Form, the market is segmented into Liquid Contrast Media, Powder Contrast Media, and Other Forms. Based on Modality, the market is segmented into X-RAY, CT, MRI, and Ultrasound. Based on Route of Administration, the market is segmented into Intravascular Route [Intravenous (IV) route, Intra-arterial (IA) route], Oral Route, Rectal Route, and Other Routes. Based on Indication, the market is segmented into Cardiovascular Disease, Cancer, Gastrointestinal Disorders, Musculoskeletal Disorders, Neurological Disorders, and Nephrological Disorders. Based on Application, the market is segmented into Radiology, Interventional Radiology, and Interventional Cardiology. Based on End User, the market is segmented into Hospitals, Clinics, And Ambulatory Surgery Centers, and Diagnostic Imaging Centers. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa. 

Contrast Media Market Analysis by Modality

The X-ray/CT sector, which accounted for around 69.53% of the market in 2021, was the biggest by modality. High-resolution 3D pictures of structures are produced with the use of X-ray/CT contrast agents. In X-ray and CT procedures, barium-based and iodinated contrast fluids are employed. When supplied or injected into the body, barium and iodine contrast agents block X-rays and prevent the rays from passing through. Images of the body's organs, blood vessels, and other tissues that momentarily contain barium- or iodinated-based contrast agents alter as a result. The widespread usage of X-ray and CT for a variety of disorders is anticipated to propel market expansion.

Over the projected period, the ultrasound market is expected to grow at the fastest rate. To see tissue microcirculation, contrast agents for ultrasound imaging have been created. Microbubbles are typically used as the modality's agents because they improve the blood's echogenicity, allowing for better imaging and evaluation of tissue vascularity, major veins, and heart cavities. The significant advantages that ultrasound contrast agents have over other imaging modalities are expected to drive the market's expansion.

Contrast Media Market Analysis by Application

In 2021, the neurological condition category accounted for around 29.45% of the market. The use of MRI contrast agents is encouraged by the diagnostic assessment of the CNS for neurological illnesses because they offer superior pictures of neural structures than CT. Gadolinium-based contrast agents are used to see demyelinated, inflammatory, and neoplastic lesions.

One in three MRIs include gadolinium-based contrast agents to improve picture quality, which increases diagnostic precision by making blood arteries, inflammation, and tumors more visible.

Over the projected period, the sector for cardiovascular illnesses is expected to expand at the fastest rate. The most often utilized technique for imaging the cardiovascular system in both adult and pediatric patients is contrast-enhanced ultrasound imaging of the cardiovascular system, also known as echocardiography. The most often used ultrasound contrast medications in the United States are Optison, Definity, and Lumason.

Contrast Media Market Analysis by Product Type

With a market share of around 66.61% in 2021, the iodinated contrast media sector was the biggest. This trend may be ascribed to the widespread use of CT and X-ray treatments as well as the availability of nonionic stable iodinated agents for enhanced diagnosis. Although iodinated contrast agents are often injected intravenously, barium-based agents may occasionally be used instead for rectal and oral delivery. CT and X-ray images are enhanced using contrast materials with an iodine basis.

They are utilized to improve vision of the brain, GI tract, internal organs, arteries, and veins. Iodinated contrast media are frequently used for a variety of reasons, including cancer, gastrointestinal, cardiovascular, musculoskeletal, neurological, and nephrological problems.

Over the projected period, the microbubble contrast media category is predicted to increase at the quickest rate. Microbubble contrast agents are tiny gas bubbles that may be injected. They are most frequently used for cardiac ultrasound imaging. For the purpose of observing tissue microcirculation, contrast agents for ultrasonic imaging have been created. They improve blood's echogenicity, which improves the ability to see and measure tissue vascularity, big veins, and heart cavities.

The capacity of microbubble contrast medium to reflect ultrasonic waves makes structures seem brighter on ultrasonography. Contrast agents for ultrasound imaging are the first-line imaging approach for a number of diseases and may be employed in a range of healthcare settings (CT suite, operating room, bedside, echo lab, and others).

Global Contrast Media Market By modality 2021 (%)

To get detailed analysis on other segments, Request For Free Sample Report

Contrast Media Market Regional Insights

North America held the largest share of the global contrast media market in 2021. It was roughly 44.44%. This is expected to change as a result of numerous strategic initiatives done by important manufacturers to target certain patient subgroups in this area. GE Healthcare, Guerbet, Lantheus, and Bracco Diagnostics are some of the major market participants.

The existence of well-established healthcare facilities, easy access to cutting-edge technology, and a strong demand for diagnostic procedures due to illness screening programs and disease management in this region are all projected to lead to an increase in inpatient exams. The number of operations could be reduced, nevertheless, as a result of healthcare reforms that impose standards for proper usage and limit needless ones.

Additionally, Asia Pacific had a substantial market share in 2021. This can be due to the region's established local and international manufacturers. For instance, one of the major contrast media manufacturing facilities of GE Healthcare is General Electric Pharmaceuticals (Shanghai) Co., Ltd., a division of GE that manufactures diagnostic pharmaceuticals (CT/MR contrast media) in China. It is projected that this element would continue to fuel regional market expansion.

Global Contrast Media Market By Geography, 2021-2028
  • Largest
  • Fastest

To know more about the market opportunities by region and country, click here to
Buy The Complete Report

Contrast Media Market Dynamics

Contrast Media Market Drivers

Rise in Chronic Illness to Bring Lucrative Opportunities during Forecast Period

  • The demand for diagnostic imaging treatments and, consequently, contrast media has significantly increased as a result of the growing incidence of chronic illnesses throughout the world. In order to provide new goods to the market and get the contrast media authorized for new indications, contrast media makers have been doing substantial R&D as a consequence of the rising demand for imaging operations. For instance, the 20-vial pack design of the ultrasound contrast agent Lumason was approved by the US FDA in 2021 for use by Bracco.

Contrast Media Market Restraints

Allergic Reaction caused by Contrast Media to Hinder its Market Growth

  • Contrast agents can be used safely in a variety of diagnostic techniques, including MRI and CT scans. However, some of the adverse effects and allergic responses linked to their usage might somewhat restrain market expansion. Their negative reactions might range from moderate to severe; nevertheless, severe reactions and major allergic reactions to contrast agents are quite infrequent.

Request Free Customization of this report to help us to meet your business objectives.

Contrast Media Market Competitive Landscape

To increase their market share in the market, major firms are implementing tactics including collaborations, acquisitions, and mergers. They are also introducing new goods.

Major players are engaging in mergers and acquisitions to broaden their consumer bases and market shares globally. Acquisitions help businesses grow their footprint by giving them a broader geographic reach and a better portfolio. In this sector, disease indication extension is common since it helps businesses win over the trust of specific population segments. Companies can target specialized patient demographics and increase the acceptance of their goods through approvals for particular indications.

Contrast Media Market Top Player's Company Profiles

  • GE Healthcare (US) 
  • Bracco Imaging S.p.A. (Italy) 
  • Bayer AG (Germany) 
  • Guerbet (France) 
  • Lantheus Medical Imaging (US) 
  • Unijules Life Sciences Ltd. (India) 
  • J.B. Chemicals & Pharmaceuticals Limited (India) 
  • Taejoon Pharm Co., Ltd. (South Korea) 
  • Jodas Expoim (India) 
  • Imax Diagnostic Imaging Limited (Ireland) 
  • Yangtze River Pharmaceutical Group (China) 
  • Livealth Biopharma (India) 
  • Beijing Beilu Pharmaceutical Co., Ltd. (China) 
  • Unispire Biopharma Private Limited (India) 
  • Arco Lifesciences (I) Pvt. Ltd. (India) 
  • Stanex Drugs & Chemicals Pvt. Ltd. (India) 
  • Rege Imaging & Cine Films Private Limited (India) 
  • K Diam Exim (India) 
  • Onko Ilaç San. ve Tic. A.S. (Turkey) 
  • Fresenius Kabi (Germany) 
  • Biem Ilaç San. ve Tic. A.S. (Turkey) 
  • Advacare Pharma (US)

Contrast Media Market Recent Developments

  • In February 2022, Lopamidal from Beijing Beilu Pharmaceutical passed the Consistency Evaluation for generic pharmaceuticals. The evaluation aids in comparing the quality and effectiveness of generic medications to those of the brand-name equivalents.

Contrast Media Key Market Trends

  • A kind of intravenous radiocontrast (radiographic dye) called iodinated contrast medium makes vascular systems and organs more visible during radiographic operations. The iodinated contrast has aided in the identification of disorders like cancer by improving visibility. The 2, 4, and 6 tri-iodinated benzene rings were chemically modified to create the iodinated contrast media that are currently in use.
  • The quantity of iodine molecules in the tissue to be photographed determines how well an iodinated contrast medium attenuates X-rays, and this relationship is inversely linked to the X-ray energy employed for imaging. As a result, the kind and quantity of contrast media utilized for a particular purpose rely on the required imaging qualities.

Contrast Media Market SkyQuest Analysis

SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Co-relates, and Analyses the Data collected utilizing Primary Exploratory Research backed by the robust Secondary Desk research.

According to our global contrast media market analysis, the market provides opportunity to players and the growth of market will be attributed to rising prevalence of chronic diseases, increasing approval of contrast agents and increasing demand for early disease, diagnosis and availability of reimbursement. It is predicted that during the forecast period, competition is expected to greatly intensify the market and will pave the way for entry of generic counterparts.

Report Metric Details
Market size value in 2022 USD 6.10 billion
Market size value in 2031 USD 11.60 billion
Growth Rate 7.4%
Base year 2023
Forecast period 2024-2031
Forecast Unit (Value) USD Billion
Segments covered
  • Type
    • Iodinated Contrast Media, Gadolinium-based Contrast Media, Microbubble Contrast Media, Barium-based Contrast Media
  • Form
    • Liquid Contrast Media, Powder Contrast Media, Other Forms
  • Modality
    • X-RAY, CT, MRI, Ultrasound
  • Route of Administration
    • Intravascular Route [Intravenous (IV) route, Intra-arterial (IA) route], Oral Route, Rectal Route, Other Routes
  • Indication
    • Cardiovascular Disease, Cancer, Gastrointestinal Disorders, Musculoskeletal Disorders, Neurological Disorders, Nephrological Disorders
  • Application
    • Radiology, Interventional Radiology, Interventional Cardiology
  • End User
    • Hospitals, Clinics, And Ambulatory Surgery Centers, Diagnostic Imaging Centers
Regions covered North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA)
Companies covered
  • GE Healthcare (US) 
  • Bracco Imaging S.p.A. (Italy) 
  • Bayer AG (Germany) 
  • Guerbet (France) 
  • Lantheus Medical Imaging (US) 
  • Unijules Life Sciences Ltd. (India) 
  • J.B. Chemicals & Pharmaceuticals Limited (India) 
  • Taejoon Pharm Co., Ltd. (South Korea) 
  • Jodas Expoim (India) 
  • Imax Diagnostic Imaging Limited (Ireland) 
  • Yangtze River Pharmaceutical Group (China) 
  • Livealth Biopharma (India) 
  • Beijing Beilu Pharmaceutical Co., Ltd. (China) 
  • Unispire Biopharma Private Limited (India) 
  • Arco Lifesciences (I) Pvt. Ltd. (India) 
  • Stanex Drugs & Chemicals Pvt. Ltd. (India) 
  • Rege Imaging & Cine Films Private Limited (India) 
  • K Diam Exim (India) 
  • Onko Ilaç San. ve Tic. A.S. (Turkey) 
  • Fresenius Kabi (Germany) 
  • Biem Ilaç San. ve Tic. A.S. (Turkey) 
  • Advacare Pharma (US)
Customization scope

Free report customization with purchase. Customization includes:-

  • Segments by type, application, etc
  • Company profile
  • Market dynamics & outlook
  • Region

To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.

Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share

Table Of Content

Executive Summary

Market overview

  • Exhibit: Executive Summary – Chart on Market Overview
  • Exhibit: Executive Summary – Data Table on Market Overview
  • Exhibit: Executive Summary – Chart on Contrast Media Market Characteristics
  • Exhibit: Executive Summary – Chart on Market by Geography
  • Exhibit: Executive Summary – Chart on Market Segmentation
  • Exhibit: Executive Summary – Chart on Incremental Growth
  • Exhibit: Executive Summary – Data Table on Incremental Growth
  • Exhibit: Executive Summary – Chart on Vendor Market Positioning

Parent Market Analysis

Market overview

Market size

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • SWOT Analysis

KEY MARKET INSIGHTS

  • Technology Analysis
    • (Exhibit: Data Table: Name of technology and details)
  • Pricing Analysis
    • (Exhibit: Data Table: Name of technology and pricing details)
  • Supply Chain Analysis
    • (Exhibit: Detailed Supply Chain Presentation)
  • Value Chain Analysis
    • (Exhibit: Detailed Value Chain Presentation)
  • Ecosystem Of the Market
    • Exhibit: Parent Market Ecosystem Market Analysis
    • Exhibit: Market Characteristics of Parent Market
  • IP Analysis
    • (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
  • Trade Analysis
    • (Exhibit: Data Table: Import and Export data details)
  • Startup Analysis
    • (Exhibit: Data Table: Emerging startups details)
  • Raw Material Analysis
    • (Exhibit: Data Table: Mapping of key raw materials)
  • Innovation Matrix
    • (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
  • Pipeline product Analysis
    • (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
  • Macroeconomic Indicators

COVID IMPACT

  • Introduction
  • Impact On Economy—scenario Assessment
    • Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
  • Revised Market Size
    • Exhibit: Data Table on Contrast Media Market size and forecast 2021-2027 ($ million)
  • Impact Of COVID On Key Segments
    • Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
  • COVID Strategies By Company
    • Exhibit: Analysis on key strategies adopted by companies

MARKET DYNAMICS & OUTLOOK

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • Regulatory Landscape
    • Exhibit: Data Table on regulation from different region
  • SWOT Analysis
  • Porters Analysis
    • Competitive rivalry
      • Exhibit: Competitive rivalry Impact of key factors, 2021
    • Threat of substitute products
      • Exhibit: Threat of Substitute Products Impact of key factors, 2021
    • Bargaining power of buyers
      • Exhibit: buyers bargaining power Impact of key factors, 2021
    • Threat of new entrants
      • Exhibit: Threat of new entrants Impact of key factors, 2021
    • Bargaining power of suppliers
      • Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
  • Skyquest special insights on future disruptions
    • Political Impact
    • Economic impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Market Size by Region

  • Chart on Market share by geography 2021-2027 (%)
  • Data Table on Market share by geography 2021-2027(%)
  • North America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • USA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Canada
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Europe
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Germany
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Spain
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • France
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • UK
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Europe
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Asia Pacific
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • China
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • India
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Japan
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Korea
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Asia Pacific
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Latin America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Brazil
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of South America
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Middle East & Africa (MEA)
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • GCC Countries
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Africa
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of MEA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)

KEY COMPANY PROFILES

  • Competitive Landscape
    • Total number of companies covered
      • Exhibit: companies covered in the report, 2021
    • Top companies market positioning
      • Exhibit: company positioning matrix, 2021
    • Top companies market Share
      • Exhibit: Pie chart analysis on company market share, 2021(%)

Methodology

For the Contrast Media Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:

1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.

2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Contrast Media Market.

3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.

4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.

Analyst Support

Customization Options

With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Contrast Media Market:

Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.

Regional Analysis: Further analysis of the Contrast Media Market for additional countries.

Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.

Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.

Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.

Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.

Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.

Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.

$5,300
BUY NOW

REQUEST FOR SAMPLE

Want to customize this report?
REQUEST FREE CUSTOMIZATION

FAQs

Global Contrast Media Market size was valued at USD 6.10 billion in 2022 and is poised to grow from USD 6.55 billion in 2023 to USD 11.60 billion by 2031, growing at a CAGR of 7.4% during the forecast period (2024-2031).

To increase their market share in the market, major firms are implementing tactics including collaborations, acquisitions, and mergers. They are also introducing new goods. 'GE Healthcare (US) ', 'Bracco Imaging S.p.A. (Italy) ', 'Bayer AG (Germany) ', 'Guerbet (France) ', 'Lantheus Medical Imaging (US) ', 'Unijules Life Sciences Ltd. (India) ', 'J.B. Chemicals & Pharmaceuticals Limited (India) ', 'Taejoon Pharm Co., Ltd. (South Korea) ', 'Jodas Expoim (India) ', 'Imax Diagnostic Imaging Limited (Ireland) ', 'Yangtze River Pharmaceutical Group (China) ', 'Livealth Biopharma (India) ', 'Beijing Beilu Pharmaceutical Co., Ltd. (China) ', 'Unispire Biopharma Private Limited (India) ', 'Arco Lifesciences (I) Pvt. Ltd. (India) ', 'Stanex Drugs & Chemicals Pvt. Ltd. (India) ', 'Rege Imaging & Cine Films Private Limited (India) ', 'K Diam Exim (India) ', 'Onko Ilaç San. ve Tic. A.S. (Turkey) ', 'Fresenius Kabi (Germany) ', 'Biem Ilaç San. ve Tic. A.S. (Turkey) ', 'Advacare Pharma (US)'

The demand for diagnostic imaging treatments and, consequently, contrast media has significantly increased as a result of the growing incidence of chronic illnesses throughout the world. In order to provide new goods to the market and get the contrast media authorized for new indications, contrast media makers have been doing substantial R&D as a consequence of the rising demand for imaging operations. For instance, the 20-vial pack design of the ultrasound contrast agent Lumason was approved by the US FDA in 2021 for use by Bracco.

A kind of intravenous radiocontrast (radiographic dye) called iodinated contrast medium makes vascular systems and organs more visible during radiographic operations. The iodinated contrast has aided in the identification of disorders like cancer by improving visibility. The 2, 4, and 6 tri-iodinated benzene rings were chemically modified to create the iodinated contrast media that are currently in use.

North America held the largest share of the global contrast media market in 2021. It was roughly 44.44%. This is expected to change as a result of numerous strategic initiatives done by important manufacturers to target certain patient subgroups in this area. GE Healthcare, Guerbet, Lantheus, and Bracco Diagnostics are some of the major market participants.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Contrast Media Market

Report ID: SQMIG35B2070

sales@skyquestt.com
USA +1 351-333-4748

BUY NOW GET FREE SAMPLE